Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/26/2000 | EP0973924A1 Recombinant chimeric viruses and uses thereof |
01/26/2000 | EP0973923A1 IMPROVED ASSAYS FOR $g(b)-AMYLOID PROCESSING |
01/26/2000 | EP0973922A2 Strawberry fruit promoters for gene expression |
01/26/2000 | EP0973921A1 2-deoxyglucose-6-phosphate (2-dog-6-p) phosphatase dna sequences as selection markers in plants |
01/26/2000 | EP0973920A1 An oleosin 5' regulatory region for the modification of plant seed lipid composition |
01/26/2000 | EP0973919A1 Plant 4-alpha-glucanotransferases |
01/26/2000 | EP0973918A1 Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal rna encoding domain, particularly with kluyveromyces |
01/26/2000 | EP0973917A1 Agrobacterium mediated transformation of moulds, in particular those belonging to the genus aspergillus |
01/26/2000 | EP0973916A1 Composition and method for inducing an immune response against tumour-related antigens |
01/26/2000 | EP0973915A1 Recombinant microorganisms capable of fermenting cellobiose |
01/26/2000 | EP0973914A1 Proteins having lecithin-cholesterol acyltransferase-like activity, their production and use |
01/26/2000 | EP0973913A1 Soybean plant producing seeds with reduced levels of raffinose saccharides and phytic acid |
01/26/2000 | EP0973912A1 Inducible plant promoters |
01/26/2000 | EP0973910A1 Bacillus thuringiensis toxins |
01/26/2000 | EP0973909A2 Process for extracting and purifying recombinant, non-lipidised osp-protein |
01/26/2000 | EP0973908A2 Plants with controlled side-shoot formation and/or controlled abscission area formation |
01/26/2000 | EP0973907A1 Control of floral induction in plants and uses therefor |
01/26/2000 | EP0973906A1 Strawberry promoters and genes |
01/26/2000 | EP0973905A1 Plant pyruvate dehydrogenase kinase gene |
01/26/2000 | EP0973904A1 COMPOSITIONS AND USE OF M-CSF-alpha |
01/26/2000 | EP0973903A2 Protein for inhibiting apoptosis |
01/26/2000 | EP0973902A1 Radioisotope concentrator methods and compositions |
01/26/2000 | EP0973901A2 Flip gene and flip protein |
01/26/2000 | EP0973900A1 flt3 LIGAND CHIMERIC PROTEINS |
01/26/2000 | EP0973899A2 SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
01/26/2000 | EP0973898A2 SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
01/26/2000 | EP0973897A1 Human tumor-associated membrane protein |
01/26/2000 | EP0973896A2 SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
01/26/2000 | EP0973895A1 Transcription factor islet-brain 1 (ib1) |
01/26/2000 | EP0973894A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
01/26/2000 | EP0973893A1 Intracellular amyloid-beta binding (erab) polypeptide |
01/26/2000 | EP0973892A2 28 human secreted proteins |
01/26/2000 | EP0973891A1 Human chemokine receptor-like chemokine |
01/26/2000 | EP0973890A2 Secreted proteins and polynucleotides encoding them |
01/26/2000 | EP0973889A1 Human calcium channels alfa1 subunits and related probes, cell lines and methods |
01/26/2000 | EP0973888A1 Dendritic cell-derived growth factor |
01/26/2000 | EP0973887A1 Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
01/26/2000 | EP0973885A1 Disassociation of interacting molecules |
01/26/2000 | EP0973884A1 Phosphate-deficiency inducible promoter |
01/26/2000 | EP0973883A2 Method of purifying dna in a cross-flow centrifuge |
01/26/2000 | EP0973882A1 DEVELOPMENT OF HIGH-ETHANOL RESISTANT $i(ESCHERICHIA COLI) |
01/26/2000 | EP0973881A2 Mycobacterium recombinant vaccines |
01/26/2000 | EP0973880A2 Chimeric genes and methods for increasing the lysine content of the seeds of plants |
01/26/2000 | EP0973879A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
01/26/2000 | EP0973876A1 DNA ENCODING $i(PNEUMOCYSTIS CARINII) PROTEASE |
01/26/2000 | EP0973874A2 Enzyme assay for mutant firefly luciferase |
01/26/2000 | EP0973871A1 Method of cloning animals |
01/26/2000 | EP0973868A1 Evaluation of changes in breast cells using nipple aspirate fluid |
01/26/2000 | EP0973867A1 Cell culture media for enhanced protein production |
01/26/2000 | EP0973866A1 Adenovirus e1-complementing cell lines |
01/26/2000 | EP0973864A1 Novel microorganisms |
01/26/2000 | EP0973805A1 Method for production of antibodies to specific sites of rapamycin |
01/26/2000 | EP0973804A2 Anti-vegf antibodies |
01/26/2000 | EP0973803A1 Peptides useful for reducing symptoms of toxic shock syndrome |
01/26/2000 | EP0973800A1 Novel receptor |
01/26/2000 | EP0973799A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
01/26/2000 | EP0973794A1 Netrin receptors |
01/26/2000 | EP0973740A1 Design, synthesis and use of specific polyamide dna-binding ligands |
01/26/2000 | EP0973550A1 Antagonistic anti-avb3 integrin antibodies |
01/26/2000 | EP0973547A1 Improving binding affinity of antigenic peptides for mhc molecules |
01/26/2000 | EP0973538A1 Modified proteins which bind extracellular matrix components |
01/26/2000 | EP0973536A1 Restenosis/atherosclerosis diagnosis, prophylaxis and therapy |
01/26/2000 | EP0973399A1 Improved method for preparing flour doughs and products made from such doughs using glycerol oxidase |
01/26/2000 | EP0973394A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO $i(HELICOBACTER PYLORI) AND VACCINE COMPOSITIONS THEREOF |
01/26/2000 | EP0973391A1 Endoderm, cardiac and neural inducing factors |
01/26/2000 | EP0973380A1 Model for chronic cerebral inflammation by intracerebral injection of polynucleotide |
01/26/2000 | EP0973374A1 Dna sequences encoding solanidine udp-glucose glucosyltransferase and use to reduce glycoalkaloids in solanaceous plants |
01/26/2000 | EP0871705A4 Human ccn-like growth factor |
01/26/2000 | EP0799305A4 Transgenic animal lacking native amyloid precursor protein |
01/26/2000 | EP0700305B1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
01/26/2000 | EP0600877B1 Selection of ribozymes that efficiently cleave target rna |
01/26/2000 | CN1242803A Glyphosate resistant transgenic plants |
01/26/2000 | CN1242802A Notch protein and their ligands |
01/26/2000 | CN1242431A Improved difference displaying polymerase chain reaction method |
01/26/2000 | CN1242428A Gene engineering carrier for recombination salvation linearization silk worm nuclear polyhedral virus |
01/26/2000 | CN1242427A Clone, expression and series determination integrated carrier, and the use thereof |
01/26/2000 | CN1242426A HSV-1 virus carrier system, method for building-up and quick guiding-in therewith |
01/26/2000 | CN1242376A Human nervous specific expression gene |
01/26/2000 | CN1048731C Polynucleotide of drug binding protein as coded CSAID |
01/25/2000 | US6018106 Use of yeast poly (A) binding proteins and their genes for broad range protection of plants against bacterial, fungal and viral pathogens |
01/25/2000 | US6018105 Nucleotide sequences; for expressing modified forms of herbicide target enzymes for herbicide resistant plants |
01/25/2000 | US6018104 Nucleic acid promoter fragment isolated from a plant tryptophan synthase alpha subunit (trpA) gene |
01/25/2000 | US6018103 Chimeric plant genes possessing independent regulatory sequences |
01/25/2000 | US6018102 A recombinant dna molecule encoding a stabilized protein; where the dna is capable of replication but not expression in a prokaryotic cell and is capable of expression in eukaryotic cell; fungicides, viricides, bactericides, antiprotozoa agent |
01/25/2000 | US6018100 A full length transcript promoter from a figwort mosaic virus; production of transgenic plants |
01/25/2000 | US6018099 A transgenic corn plant containing a chimeric gene which comprises a promoter sequence that directs transcription in roots; genetic engineering |
01/25/2000 | US6018097 Transgenic mice expressing human insulin |
01/25/2000 | US6018042 An oligonucleotide derivative capable of modulating the biosynthesis of human s-adenosylmethionine decarboxylase enzyme; antiproliferative/antitumor/antimetastasis agents |
01/25/2000 | US6018040 Fish insulin-like growth factor 11 promoter |
01/25/2000 | US6018039 A recombinant nucleotide sequence with an exogenous gene coding region is inserted at a targeted position; for producing transgenic animals for the expression of a desired substance in the mammary gland or tissue of an animal |
01/25/2000 | US6018038 Incompatible plant and pathogen interaction related gene |
01/25/2000 | US6018037 A recombinant dna coding for a peptide containing leucine instead of the usual 13th amino acid methionine; production of motilin; therapuetic applications |
01/25/2000 | US6018036 A nucleic acid molecule; therapy and diagnosis of systemic lupus erythematosis, leishmaniasis, myasthenia gravis, skin disorders; antidiabetic/antiarthritic/antiprotozia agents; parasiticides |
01/25/2000 | US6018030 Recombinant proteins that contain at least 50 percent of amino acids of naturally occuring repeating sequences; genetic engineering of structural components of prosthetic devices and synthetic fibers |
01/25/2000 | US6018029 DNA encoding canine interleukin-1 receptor antagonist |
01/25/2000 | US6018026 For rapid, inexpensive and adaptable high volume screening of ligands to receptors; for determining the presence of cell growth factors in samples; for purifying cell growth factors and isoforms |
01/25/2000 | US6018025 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd528 as a target |
01/25/2000 | US6018024 A soluble fragment of amyloid protein having the carboxy terminal methionine or leucine amino acid resulting from cleavage of the intact protein; diagnosis and therapy for alzheimer's disease |
01/25/2000 | US6018023 Kainate-binding, human CNS receptors of the EAA3 family |
01/25/2000 | US6018020 Amino acid derivatives |